Cover Image

In Vivo Knockout of the Vegfa Gene by Lentiviral Delivery of CRISPR/Cas9 in Mouse Retinal Pigment Epithelium Cells

Virus-based gene therapy by CRISPR/Cas9-mediated genome editing and knockout may provide a new option for treatment of inherited and acquired ocular diseases of the retina. In support of this notion, we show that Streptococcus pyogenes (Sp) Cas9, delivered by lentiviral vectors (LVs), can be used in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andreas Holmgaard (Author), Anne Louise Askou (Author), Josephine Natalia Esther Benckendorff (Author), Emil Aagaard Thomsen (Author), Yujia Cai (Author), Toke Bek (Author), Jacob Giehm Mikkelsen (Author), Thomas J. Corydon (Author)
Format:	Book
Published:	Elsevier, 2017-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CRISPR-Cas9-directed gene tagging using a single integrase-defective lentiviral vector carrying a transposase-based Cas9 off switch
by: Emil Aagaard Thomsen, et al.
Published: (2022)

Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
by: Anne Louise Askou, et al.
Published: (2019)

Improved Lentiviral Gene Delivery to Mouse Liver by Hydrodynamic Vector Injection through Tail Vein
by: Trine Dalsgaard, et al.
Published: (2018)

Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope
by: Ángela Covo-Vergara, et al.
Published: (2024)

Production of Knockout Mice using CRISPR/Cas9 in FVB Strain
by: Hee Sook Bae, et al.
Published: (2015)

User-Friendly Genetic Conditional Knockout Strategies by CRISPR/Cas9
by: Liangliang Chen, et al.
Published: (2018)

Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles
by: Ian Helstrup Nielsen, et al.
Published: (2024)

VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy
by: Sidsel Alsing, et al.
Published: (2022)

CRISPR/Cas9 RET Gene Knockout in Medullary Thyroid Carcinoma Cell-lines: Optimization and Validation
by: Marjan Zarif-Yeganeh, et al.
Published: (2022)

Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
by: Yvonne Knopp, et al.
Published: (2018)

Knockout of ABC transporters by CRISPR/Cas9 contributes to reliable and accurate transporter substrate identification for drug discovery
by: Dongyan Feng, et al.
Published: (2022)

Screening Genes Promoting Exit from Naive Pluripotency Based on Genome-Scale CRISPR-Cas9 Knockout
by: Bin Yang, et al.
Published: (2020)

CRISPR-Cas9 knockout of membrane-bound alkaline phosphatase or cadherin does not confer resistance to Cry toxins in Aedes aegypti.
by: Sabino Pacheco, et al.
Published: (2024)

Poly(Beta-Amino Ester) Nanoparticles Enable Nonviral Delivery of CRISPR-Cas9 Plasmids for Gene Knockout and Gene Deletion
by: Yuan Rui, et al.
Published: (2020)

Construction and Evaluation of a Novel Organic Anion Transporter 1/3 CRISPR/Cas9 Double-Knockout Rat Model
by: Xueyan Gou, et al.
Published: (2022)

Single-Dose Lentiviral Mediated Gene Therapy Recovers CFTR Function in Cystic Fibrosis Knockout Rats
by: Nicole Reyne, et al.
Published: (2021)

Utilization of proliferable extracellular amastigotes for transient gene expression, drug sensitivity assay, and CRISPR/Cas9-mediated gene knockout in Trypanosoma cruzi.
by: Yuko Takagi, et al.
Published: (2019)

Production of Cloned Pigs Derived from Double Gene Knockout Cells Using CRISPR/Cas9 System and MACS-based Enrichment System
by: Bumrae Cho, et al.
Published: (2018)

Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy
by: Alexandra McCarron, et al.
Published: (2021)

The Impact of CRISPR-Cas System on Antiviral Therapy
by: Hadi Bayat, et al.
Published: (2018)

Application of CRISPR/Cas9 in plant biology
by: Xuan Liu, et al.
Published: (2017)

CRISPR/Cas9 knockout of female-biased genes AeAct-4 or myo-fem in Ae. aegypti results in a flightless phenotype in female, but not male mosquitoes.
by: Sarah O'Leary, et al.
Published: (2020)

Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease
by: Xinrun Ma, et al.
Published: (2020)

Principles and medical applications of gene editing by CRISPR / Cas
by: Rolando Sánchez Artigas, et al.
Published: (2021)

Optimization of CRISPR-Cas system for clinical cancer therapy
by: Xiang Meng, et al.
Published: (2023)

CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017)

CRISPR/Cas-based CAR-T cells: production and application
by: Ping Song, et al.
Published: (2024)

Targeting Hepatitis B Virus With CRISPR/Cas9
by: Christoph Seeger, et al.
Published: (2014)

The CRISPR/Cas9 System Delivered by Extracellular Vesicles
by: Xinglong Zhu, et al.
Published: (2023)

Generation of desminopathy in rats using CRISPR‐Cas9
by: Henning T. Langer, et al.
Published: (2020)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
by: Bing Shui, et al.
Published: (2016)

Bioinformatics investigation of CRISPR/Cas systems in Bifidobacterium longum
by: Amir Zarrinhaghighi, et al.
Published: (2021)

Radiolabeled 15-mer peptide internalization is mediated by megalin (LRP2 receptor) in a CRISPR/Cas9-based LRP2 knockout human kidney cell model
by: Anna Durinova, et al.
Published: (2024)

CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics
by: Fikre Birhanu Balcha, et al.
Published: (2023)

CRISPR-Cas13a Inhibits HIV-1 Infection
by: Lijuan Yin, et al.
Published: (2020)

CRISPR/Cas9 systems: Delivery technologies and biomedical applications
by: Yimin Du, et al.
Published: (2023)

Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction
by: Emily Xia, et al.
Published: (2018)

Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
by: He X, et al.
Published: (2022)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
by: Wei-Jing Dai, et al.
Published: (2016)

Correction: CRISPR/Cas-based CAR-T cells: production and application
by: Ping Song, et al.
Published: (2024)